Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

We're really ripe for partnership at this point.

1. We're not bankrupt. $10M in cash with a payroll around $1M/year.
2. We can't really raise more funds on our own.
3. We have at least two pipeline assets ready to move forward. Possibly four counting Kevetrin and any antiviral/bacterial indications.
4. Leo isn't 55 anymore. At 62 it's time to set aside delusions of being the next Regeneron and sign some deals to secure his family's future.

$100M upfront and all Brilacidin development costs in exchange for a 8% royalty?

Then we can take that and swing for the fences on Kevetrin.